Investors were kind to GM salmon pioneer AquaBounty Technologies in the hours immediately following its announcement on Friday that the US Food and Drug Administration (FDA) was lifting a 2016 import alert that prevented AquaBounty's AquAdvantage genetically engineered salmon and salmon eggs from entering the United States.
The challenge now shifts from navigating regulations to making agreements with buyers.